2025-01-29 11:34:00 :
Star Health and Allied Insurance Q3 Result 2025: Star Health and Allied Insurance on January 28, 2025 announced their third quarter results, showing a year -on -year increase of 15.72 %. However, the company’s profits have been hit by a major blow, a year -on -year decrease of 25.7 % Bleak215.14 million, revenue reached Bleak3999.63 million.
Compared with the previous quarter, revenue increased by 2.23 %, while the profit growth rate was 93.31 %. This contrast highlights the fluctuation of the company’s financial performance.
this
Star Health and Allied Insurance Q3 results
It is also pointed out that sales, generally and administrative expenses, decreased by 6.22 % in a quarter quarter, but increased by 5.74 % year -on -year. This shows the tightening of operating costs in the last quarter.
The amazing operating income increased by 30788.89 %, but it fell 47.62 % year -on -year, indicating that revenue performance fluctuations in different periods.
The company’s earnings per share (EPS) report on Q3 Bleak3.62, reported a year -on -year decrease of 25.51 %. This decline in EPS may involve investors looking for profitable indicators.
Star Health and Allied Insurance has gone through a challenging period in the stock market. The return rate in the past week was -3.97 %, and the return rate in the past six months was -27.74 %, full of -6.34 %.
Currently, Star Health and Allied Insurance owns Bleak26142.92 million, the height is 52 weeks Bleak647 and low Bleak438, indicating that the price fluctuates significantly.
As of January 29, 2025, among the 20 analysts covering the company, the rating was mixed together: 2 analysts gave high selling rating, 4 selling rating, 2 holding rating, and 2 holding rating. 4 buy rating and 8 strong buy rating.
The consensus suggestion on this date is to buy, indicating that although the recent challenges are facing challenges, analysts have maintained a positive view of the company’s future performance.
Star Health and Allied Insurance Financials
| period | Q3 (FY25) | Q2 (FY25) | QOQ growth | Q3 (FY24) | Annual growth |
|---|---|---|---|---|---|
| Total income | 3999.63 | 3912.28 | +2.23 % | 3456.25 | +15.72 % |
| Sales/general/management costs total | 466.52 | 497.45 | -6.22 % | 441.19 | +5.74 % |
| Total operating expenses | 3860.63 | 3911.83 | -1.31 % | 3190.88 | +20.99 % |
| Operating income | 139 | 0.45 | +30788.89 % | 265.37 | -47.62 % |
| Net income before tax | 286.96 | 148.8 | +92.85 % | 387.67 | -25.98 % |
| net income | 215.14 | 111.29 | +93.31 % | 289.55 | -25.7 % |
| Diluted normalization EPS | 3.62 | 1.87 | +93.58 % | 4.86 | -25.51 % |
Disclaimer: This is a live blog generated by AI, which has not been edited by Livemint employeesEssence
Follow us On Social Media Twitter/X
